Millennium Management LLC reduced its holdings in Eyenovia Inc (NASDAQ:EYEN) by 3.8% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 261,485 shares of the company’s stock after selling 10,339 shares during the quarter. Millennium Management LLC’s holdings in Eyenovia were worth $1,647,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several research firms recently commented on EYEN. HC Wainwright began coverage on Eyenovia in a research report on Tuesday, October 9th. They issued a “buy” rating and a $12.00 target price on the stock. Zacks Investment Research upgraded Eyenovia from a “hold” rating to a “buy” rating and set a $6.25 target price on the stock in a research report on Friday, August 17th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $18.31.
Shares of EYEN stock opened at $3.93 on Tuesday. Eyenovia Inc has a 1 year low of $2.94 and a 1 year high of $10.74. The firm has a market cap of $37.69 million and a PE ratio of -1.79.
Eyenovia Company Profile
Eyenovia, Inc, a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat, which is in Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia.
Further Reading: Float
Want to see what other hedge funds are holding EYEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eyenovia Inc (NASDAQ:EYEN).
Receive News & Ratings for Eyenovia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eyenovia and related companies with MarketBeat.com's FREE daily email newsletter.